Aller au contenu principal
Profil bibliographique

Alessia Salemme

Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.

9Publications signalées
20Citations signalées
2Affiliations récentes

Les institutions déclarées

Les domaines associés

Lymphoma Diagnosis and TreatmentBreast Cancer Treatment StudiesPlatelet Disorders and TreatmentsChemotherapy-induced cardiotoxicity and mitigationCNS Lymphoma Diagnosis and Treatment

Les publications récentes

Accès ouvert 2026 article OpenAlex

Breast cancer risk in female survivors of Hodgkin lymphoma after exposure to non-pegylated liposomal doxorubicin at young adult and adult age: the first real-life series from Southern Italy cancer centers

Marco Picardi, Annamaria Vincenzi, Claudia Giordano, Novella Pugliese et autres

Studies in female Hodgkin lymphoma (HL) survivors have shown that doxorubicin hydrochloride exposure at young adult and adult (YA&A) age is associated with an increased risk of breast cancer (BC) regardless of chest-radiotherapy (c-RT). Although non-pegylated liposomal doxorubicin (NPLD)-based regimens have shown …

it (code pays fourni par la source)

0 citations Annals of Hematology
Accès ouvert 2025 article OpenAlex

Brentuximab Vedotin With Adriamycin, Vinblastine, and Dacarbazine for Patients Aged 18–59 Years With Untreated Advanced Stage Classical Hodgkin Lymphoma: The Largest Real‐Life Series From Southern Italy Cancer Centers

Marco Picardi, Annamaria Vincenzi, Claudia Giordano, Novella Pugliese et autres

BV + AVD is increasingly used for frontline treatment of stage III/IV cHL. Young adults and adults (Ya&A) were the most common patients treated with BV + AVD in clinical trials but have not been studied in non-trial settings. We conducted a …

it, cz (code pays fourni par la source)

3 citations European Journal Of Haematology
Accès ouvert 2025 article OpenAlex

Clinician’s knowledge and awareness of patient-reported outcomes in immune thrombocytopenia: Results of a national survey (ITP NET, GIMEMA Working Group Anemia and Thrombocytopenia)

Esther Natalie Olíva, Fabio Efficace, Maria Rosa Valvano, Paola Arcuri et autres

Background: Patient-reported outcomes (PROs) are increasingly recognized in hematology, yet clinician awareness remains limited. In immune thrombocytopenia (ITP), an autoimmune disease, symptoms like fatigue impact quality of life (QoL). Design and Methods: This Italian survey evaluated hematologists' knowledge of PROs within the …

it, jp (code pays fourni par la source)

0 citations Journal of Public Health Research
2024 conference-abstract OpenAlex

Clinician's Knowledge and Awareness of Patient-Reported Outcomes in Immune Thrombocytopenia: Results of a National Survey (ITP NET, GIMEMA Working Group Anemia and Thrombocytopenia)

Esther Natalie Olíva, Fabio Efficace, Maria Rosa Valvano, Paola Arcuri et autres

Background: Patient-reported outcomes (PROs) are gaining attention in hematological diseases. Nonetheless, clinicians' knowledge of PROs is not widespread. Immune thrombocytopenia (ITP) is an autoimmune hematological disease in which fatigue significantly impacts patients' quality of life (QoL).This national Italian study focused on assessing …

it, gr (code pays fourni par la source)

0 citations Blood
Accès ouvert 2024 article OpenAlex

Liposomal Doxorubicin, Vinblastine and Dacarbazine Plus Consolidation Radiotherapy of Residual Nodal Masses for Frontline Treatment in Older Adults With Advanced Stage Classic Hodgkin Lymphoma: Improved Outcome in a Multi‐Center Real‐Life Study

Marco Picardi, Auri Marcelo Rizzo Vincenzi, Claudia Giordano, Laura De Fazio et autres

ABSTRACT In elderly patients with high‐risk classic Hodgkin lymphoma (c‐HL), we evaluated the impact of a new modality treatment without bleomycin, that is, liposomal doxorubicin (NPLD)‐based regimen plus consolidation radiotherapy of residual nodal masses (RNMs), on overall survival (OS) and progression free …

it (code pays fourni par la source)

6 citations Hematological Oncology
Accès ouvert 2023 article OpenAlex

Lamivudine 24-month-long prophylaxis is a safe and efficient choice for the prevention of hepatitis B virus reactivation in HBsAg-negative/HBcAb-positive patients with advanced DLBCL undergoing upfront R-CHOP-21

Claudia Giordano, Marco Picardi, Novella Pugliese, Annamaria Vincenzi et autres

Introduction: Occult hepatitis B infection (OBI) is a condition where replication-competent hepatitis B virus-DNA (HBV-DNA) is present in the liver, with or without HBV-DNA in the blood [<200 international units (IU)/ml or absent] in HB surface antigen (HBsAg)-negative/HB core antibody (HBcAb)-positive individuals. …

it (code pays fourni par la source)

8 citations Frontiers in Oncology
Accès ouvert 2018 article OpenAlex

Effects of a new nutraceutical combination on cognitive function in hypertensive patients

Giuseppe Giugliano, Alessia Salemme, Sara De Longis, Marialuisa Perrotta et autres

BACKGROUND: Chronic increased arterial blood pressure has been associated with executive dysfunction, slowing of attention and mental processing speed, and later with memory deficits. Due to the absence of a concrete therapeutic approach to this pathophysiological process, in the last decades there …

it, us (code pays fourni par la source)

2 citations Immunity & Ageing

BNTIC News n’est pas le producteur de ces données. Les publications sont interrogées à la demande dans Crossref, OpenAIRE, DOAJ, Europe PMC, HAL, DataCite, AfricArXiv, ROR et la Banque mondiale, sans clé d’accès. OpenAlex reste optionnel. Aucun service payant n’est nécessaire et aucune donnée externe n’est enregistrée en base. Consulter les sources et leurs limites.